Starling Oncology, Inc. (STLN)

Starling Oncology Revenue

Starling Oncology had revenue of $161.28M in the quarter ending June 30, 2026, with 34.62% growth. This brings the company's revenue in the last twelve months to $587.24M, up 38.38% year-over-year. In the year 2025, Starling Oncology had annual revenue of $502.73M with 27.79% growth.

• Revenue (ttm): $587.24M
• Revenue Growth: +38.38%
• P/S Ratio: 1.11
• Revenue / Employee: $916,137
• Employees: 641
• Market Cap: 606.40M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	502.73M	109.32M	27.79%
Dec 31, 2024	393.41M	69.17M	21.33%
Dec 31, 2023	324.24M	71.76M	28.42%
Dec 31, 2022	252.48M	49.48M	24.37%
Dec 31, 2021	203.00M	15.49M	8.26%
Dec 31, 2020	187.52M	-	-

Data Source: Fiscal.ai Last updated: Aug 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 10, 2026

Data Sources Report a data error